Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar 11;27(3):389-404.e6.
doi: 10.1016/j.chom.2020.01.006. Epub 2020 Jan 30.

Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production

Affiliations
Free article
Randomized Controlled Trial

Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production

Edward C Deehan et al. Cell Host Microbe. .
Free article

Abstract

Dietary fibers (DFs) impact the gut microbiome in ways often considered beneficial. However, it is unknown if precise and predictable manipulations of the gut microbiota, and especially its metabolic activity, can be achieved through DFs with discrete chemical structures. Using a dose-response trial with three type-IV resistant starches (RS4s) in healthy humans, we found that crystalline and phosphate cross-linked starch structures induce divergent and highly specific effects on microbiome composition that are linked to directed shifts in the output of either propionate or butyrate. The dominant RS4-induced effects were remarkably consistent within treatment groups, dose-dependent plateauing at 35 g/day, and can be explained by substrate-specific binding and utilization of the RS4s by bacterial taxa with different pathways for starch metabolism. Overall, these findings support the potential of using discrete DF structures to achieve targeted manipulations of the gut microbiome and its metabolic functions relevant to health.

Keywords: butyrate; dietary fiber; dose-response; gut microbiome; prebiotic; precision microbiome modulation; propionate; resistant starch; short-chain fatty acids.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests J.W. has received research funding and consulting fees from industry sources involved in the manufacture and marketing of DFs, including Ingredion, which supported this study and commercializes all starches used. J.W. is further a co-owner of Synbiotic Health, a developer of synbiotic products. These interests did not influence his judgement or presentation of study findings. All other authors declare no conflict of interest.

Publication types